cenegermin
Commercial- Indications
- Neurotrophic keratitis
Company intelligence / Profile preview
FarmaMondo enables patient access to innovative and specialty medicines through named patient programs and full commercialization services. It does not conduct clinical trials or report clinical results itself but partners with pharma/biotech companies to distribute their products globally where they are needed most
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FarmaMondo SA.